[1]
|
Li, H., Ding, P., Peng, B., et al. (2021) Cross-talk between Hepatic Stellate Cells and T Lymphocytes in Liver Fibrosis. Hepatobiliary & Pancreatic Diseases International, 20, 207-214. https://doi.org/10.1016/j.hbpd.2021.04.007
|
[2]
|
Ekihiro, S. and David, A.B. (2015) Recent Advancement of Molecular Mechanisms of Liver Fibrosis. Journal of Hepato-biliary-pancreatic Sciences, 22, 512-518. https://doi.org/10.1002/jhbp.245
|
[3]
|
Aydin, M.M. and Akcali, K.C. (2018) Liver Fibrosis. The Turkish Journal of Gastroenterology, 29, 14-21.
https://doi.org/10.5152/tjg.2018.17330
|
[4]
|
葛亮, 苟庆云, 赵金凤, 等. BMP-9在胆道闭锁肝纤维化中的作用机制研究[J]. 天津医药, 2021, 49(10): 1020-1025.
|
[5]
|
Li, J. and Tuo, B. (2021) Current and Emerging Approaches for Hepatic Fibrosis Treatment. Gastroenterology Research and Practice, 2021, Article 6612892. https://doi.org/10.1155/2021/6612892
|
[6]
|
郭晓玲, 孔令伟, 曹勤. 中医药治疗肝纤维化和肝硬化的研究进展[J]. 医学研究杂志, 2014, 43(11): 159-161.
|
[7]
|
杨洁, 蔡刁龙, 谭献文, 等. 柴胡、红花、川芎中药单体对大鼠肝纤维化治疗作用的实验研究[J]. 临床和实验医学杂志, 2009, 8(7): 1-3.
|
[8]
|
辛鑫, 胡义扬. 中医对肝纤维化的认识[J]. 肝博士, 2022(2): 32.
|
[9]
|
刘贤永, 杨金燕, 李柯更, 等. 基于活血化瘀法治疗肝纤维的临床经验[J]. 实用中西医结合临床, 2016, 16(5): 61-62.
|
[10]
|
王佐梅, 肖洪彬, 李雪莹, 等. 中药红花的药理作用及临床应用研究进展[J]. 中华中医药杂志, 2021, 36(11): 6608-6611.
|
[11]
|
胡谋波, 郑雪嘉, 梁娟, 等. 中药红花抗纤维化机制研究进展[J]. 湖北民族学院学报(医学版), 2016, 33(1): 66-68.
|
[12]
|
胡志伟. 红花提取物对肝纤维化大鼠肝线粒体的作用[J]. 医学研究杂志, 2018, 47(5): 108-112.
|
[13]
|
马婷, 邝晓岚, 蔡婉娜, 等. 黄酮类成分抗肝纤维化作用及其机制的研究进展[J]. 中草药, 2022, 53(13): 4146-4161.
|
[14]
|
田华, 王小平, 陈瑜, 等. 黄芩素对大鼠肝纤维化保护作用的实验研究[J]. 时珍国医国药, 2016, 27(9): 2305-2306.
|
[15]
|
Dai, C., Li, H., Wang, Y., et al. (2021) Inhibition of Oxidative Stress and ALOX12 and NF-κB Pathways Contribute to the Protective Effect of Baicalein on Carbon Tetrachloride-Induced Acute Liver Injury. Antioxidants, 10, Article 976. https://doi.org/10.3390/antiox10060976
|
[16]
|
李星霞, 李婕, 王绍展, 等. 木犀草素对肝纤维化进程中肝细胞上皮间质转化的抑制作用[J]. 中国药房, 2014, 25(19): 1729-1732.
|
[17]
|
李林林, 龚国清, 冯贻东, 等. 木犀草素对四氯化碳致大鼠肝纤维化的保护作用及其机制研究[J]. 中国生化药物杂志, 2010, 31(6): 377-380.
|
[18]
|
赵稳兴, 陈忠明, 候辉, 等. 木犀草素降低CCl_4诱导的大鼠肝纤维化[J]. 世界华人消化杂志, 2002, 7(7): 779-782.
|
[19]
|
王绍展, 王媛媛, 顾妍秋, 等. 槲皮素通过抑制TGF-β/TAK1/JNK和TGF-β/Smad2信号通路发挥抗肝纤维化的作用[J]. 中南药学, 2022, 20(5): 965-972.
|
[20]
|
陈方. 槲皮素对LPS诱导小鼠肝损伤的保护作用[D]: [硕士学位论文]. 成都: 四川农业大学, 2020
|
[21]
|
蒋炜, 邓治林, 李福昌. 槲皮素对人肝星状细胞Ⅰ、Ⅲ型胶原蛋白表达的影响与其细胞周期研究[J]. 重庆医学, 2018, 47(9): 1179-1182.
|
[22]
|
Xu, T., Huang, S., Huang, Q., et al. (2019) Kaempferol Attenuates Liver Fibrosis by Inhibiting Activin Receptor-Like Kinase 5. Journal of Cellular and Molecular Medicine, 23, 6403-6410. https://doi.org/10.1111/jcmm.14528
|
[23]
|
Zhou, G., Li, C., Zhang, R., et al. (2022) Kaempferol Inhibits Hepatic Stellate Cell Activation by Regulating miR-26b-5p/Jag1 Axis and Notch Pathway. Frontiers in Pharmacology, 13, Article 881855.
https://doi.org/10.3389/fphar.2022.881855
|
[24]
|
Reyes-Gordillo, K., Shah, R., Arellanes-Robledo, J., et al. (2019) Akt1 and Akt2 Isoforms Play Distinct Roles in Regulating the Development of Inflammation and Fibrosis Associated with Alcoholic Liver Disease. Cells, 8, Article 1337. https://doi.org/10.3390/cells8111337
|
[25]
|
Alexander, W., Matthew, M., Maria Eugenia, I., et al. (2017) NLRP3 Inflammasome Driven Liver Injury and Fibrosis: Roles of IL‐17 and TNF in Mice. Hepatology, 67, 736-749. https://doi.org/10.1002/hep.29523
|
[26]
|
Wandrer, F., Liebig, S., Marhenke, S., et al. (2020) TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice. Cell Death & Disease, 11, Article No. 212.
https://doi.org/10.1038/s41419-020-2411-6
|
[27]
|
Seo, H.Y., Lee, S.H., Lee, J.H., et al. (2020) Src Inhibition Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation and Decreasing Connective Tissue Growth Factor. Cells, 9, Article 558.
https://doi.org/10.3390/cells9030558
|
[28]
|
Wang, D., Xu, H., Fan, L., et al. (2023) Hyperphosphorylation of EGFR/ERK Signaling Facilitates Long-Term Arsenite-Induced Hepatocytes Epithelial-Mesenchymal Transition and Liver Fibrosis in Sprague-Dawley Rats. Ecotoxicology and Environmental Safety, 249, Article 114386. https://doi.org/10.1016/j.ecoenv.2022.114386
|
[29]
|
Scheving, L.A., Zhang, X., Threadgill, D.W., et al. (2016) Hepatocyte ERBB3 and EGFR are Required for Maximal CCl4-Induced Liver Fibrosis. American Journal of Physiology-Gastrointestinal and Liver Physiology, 311, G807-G816.
https://doi.org/10.1152/ajpgi.00423.2015
|
[30]
|
Thapaliya, S., Wree, A., Povero, D., et al. (2014) Caspase 3 Inactivation Protects against Hepatic Cell Death and Ameliorates Fibrogenesis in a Diet-Induced NASH Model. Digestive Diseases and Sciences, 59, 1197-206.
https://doi.org/10.1007/s10620-014-3167-6
|
[31]
|
杨星, 王振, 李淑娣, 等. 基于PI3K/Akt信号通路探讨中药活性成分抗肝纤维化的研究现状[J]. 中国实验方剂学杂志, 2023(13): 1-11.
|
[32]
|
Huang, S., Chen, S., Ma, Y., et al. (2022) Evaluation of the Mechanism of Jiedu Huazhuo Quyu Formula in Treating Wilson’s Disease-Associated Liver Fibrosis by Network Pharmacology Analysis and Molecular Dynamics Simulation. Evidence-Based Complementary and Alternative Medicine, 2022, Article 9363131.
https://doi.org/10.1155/2022/9363131
|